Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-20

Clinical Trial Update: Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the addition of ketorolac to panphotocoagulation for proliferative diabetic retinopathy, including diabetic macular edema, has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Hospital Juarez de Mexico | Conditions: Proliferative Diabetic Retinopathy, Macular Edema | Phase 2 | Status: COMPLETED